BARICITINIB INHIBITS RADIOGRAPHIC PROGRESSION OF STRUCTURAL JOINT DAMAGE AT 1 YEAR IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) AND AN INADEQUATE RESPONSE TO CSDMARDS

被引:0
|
作者
van der Heijde, D. [1 ]
Dougados, M. [2 ]
Chen, Y. -C. [3 ]
Greenwald, M. [4 ]
Drescher, E. [5 ]
Klar, R. [6 ]
Xie, L. [7 ]
de la Torre, I. [7 ]
Rooney, T. P. [7 ]
Witt, S. [7 ]
Schlichting, D. [7 ]
DeBono, S. [7 ]
Emery, P. [8 ]
机构
[1] Leiden Univ, Med Ctr, Leiden, Netherlands
[2] Cochin Hosp, Paris, France
[3] Chang Gung Mem Hosp Kaohsiung, Kaohsiung, Taiwan
[4] Desert Med Adv, Palm Desert, CA USA
[5] Veszprem Csolnoky Ferenc Cty Hosp, Veszprem, Hungary
[6] Quintiles Transnat INC, Durham, NC USA
[7] Eli Lilly & Co, Indianapolis, IN 46285 USA
[8] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England
关键词
D O I
10.1136/annrheumdis-2016-eular.1611
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
THU0168
引用
收藏
页码:244 / 245
页数:2
相关论文
共 50 条
  • [1] BARICITINIB INHIBITS RADIOGRAPHIC PROGRESSION OF STRUCTURAL JOINT DAMAGE AT 1 YEAR IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) AND AN INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (CSDMARDS)
    Genovese, M.
    Van der Heijde, D.
    Dougados, M.
    Chen, Y.
    Greenwald, M.
    Drescher, E.
    Klar, R.
    Xie, L.
    De La Torre, I
    Rooney, T.
    Witt, S.
    Schlichting, D.
    De Bono, S.
    Emery, P.
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 32 - 32
  • [2] Effects of baricitinib on radiographic progression of structural joint damage at 1 year in patients with rheumatoid arthritis and an inadequate response to conventional synthetic disease-modifying antirheumatic drugs
    van der Heijde, Desiree
    Dougados, Maxime
    Chen, Ying-Chou
    Greenwald, Maria
    Drescher, Edit
    Klar, Rena
    Xie, Li
    de la Torre, Inmaculada
    Rooney, Terence P.
    Witt, Sarah L.
    Schlichting, Douglas E.
    de Bono, Stephanie
    Emery, Paul
    RMD OPEN, 2018, 4 (01):
  • [3] Baricitinib inhibits structural joint damage progression in patients with rheumatoid arthritis—a comprehensive review
    Paul Emery
    Patrick Durez
    Axel J. Hueber
    Inmaculada de la Torre
    Esbjörn Larsson
    Thorsten Holzkämper
    Yoshiya Tanaka
    Arthritis Research & Therapy, 23
  • [4] Baricitinib inhibits structural joint damage progression in patients with rheumatoid arthritis-a comprehensive review
    Emery, Paul
    Durez, Patrick
    Hueber, Axel J.
    de la Torre, Inmaculada
    Larsson, Esbjoern
    Holzkaemper, Thorsten
    Tanaka, Yoshiya
    ARTHRITIS RESEARCH & THERAPY, 2021, 23 (01)
  • [5] Response to baricitinib therapy in patients with rheumatoid arthritis with inadequate response to csDMARDs as a function of baseline characteristics
    Kremer, Joel M.
    Schiff, Michael
    Muram, David
    Zhong, Jinglin
    Alam, Jahangir
    Genovese, Mark C.
    RMD OPEN, 2018, 4 (01):
  • [6] Radiographic Progression of Structural Joint Damage over 5 Years of Baricitinib Treatment in Patients with Rheumatoid Arthritis: Results from RA-BEYOND
    van der Heijde, Desiree
    Kartman, Cynthia E.
    Xie, Li
    Beattie, Scott
    Schlichting, Douglas
    Durez, Patrick
    Tanaka, Yoshiya
    Fleischmann, Roy
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [7] Radiographic Progression of Structural Joint Damage Over 5 Years of Baricitinib Treatment in Patients With Rheumatoid Arthritis: Results From RA-BEYOND
    van der Heijde, Desiree
    Kartman, Cynthia E.
    Xie, Li
    Beattie, Scott
    Schlichting, Douglas
    Mo, Daojun
    Durez, Patrick
    Tanaka, Yoshiya
    Fleischmann, Roy
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (02) : 133 - 141
  • [8] Radiographic progression of structural joint damage over five years of baricitinib treatment in patients with rheumatoid arthritis: results from RA-BEYOND
    van der Heijde, D.
    Kartman, C. E.
    Xie, L.
    Beattie, S.
    Schlichting, D.
    Durez, P.
    Tanaka, Y.
    Fleischmann, R.
    Hanssen-Bauer, A.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2021, 50 : 27 - 27
  • [9] RADIOGRAPHIC PROGRESSION OF STRUCTURAL JOINT DAMAGE OVER 5 YEARS OF BARICITINIB TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROM RA-BEYOND
    Van der Heijde, Desiree
    Kartman, Cynthia E.
    Xie, Li
    Beattie, Scott
    Schlichting, Douglas
    Durez, Patrick
    Tanaka, Yoshiya
    Fleischmann, Roy
    Imbert, Denisse
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 : S111 - S111
  • [10] Low rates of radiographic progression of structural joint damage over 2 years of baricitinib treatment in patients with rheumatoid arthritis
    van Der Heijde, Desiree
    Schiff, Michael
    Tanaka, Yoshiya
    Xie, Li
    Meszaros, Gabriella
    Ishii, Taeko
    Casillas, Marta
    Ortmann, Robert A.
    Emery, Paul
    RMD OPEN, 2019, 5 (01):